This is another type of estrogen medicine. It's made by linking estrogens to fatty acids. This makes them more stable and longer-lasting in the body. It's also used to help with symptoms of low estrogen, like hot flashes.
Every report comes from a Lived member, sent anonymously.
Have you tried Esterified Estrogens for Hot Flashes?
Esterified estrogens is an estrogen medicine taken as a tablet. It is a blend of estrogen compounds, mostly estrone sulfate, and it is one form of menopausal hormone therapy. As a single-ingredient tablet it was approved to treat moderate to severe hot flashes and night sweats of menopause, and moderate to severe vaginal dryness and thinning caused by menopause. It was also approved to replace estrogen when the ovaries make too little, such as with primary ovarian failure or after surgical removal of the ovaries, and at much higher doses to ease symptoms of advanced breast or prostate cancer in selected patients. In the US, the Food and Drug Administration (FDA) now lists every single-ingredient esterified estrogens product, including the former brand Menest, as discontinued. The form people are most likely to be prescribed today combines esterified estrogens with methyltestosterone, a synthetic version of the male hormone testosterone. It is sold as Estratest and as generic esterified estrogens and methyltestosterone tablets (sometimes shortened to EEMT). Its label limits it to menopausal hot flashes that have not improved on estrogen alone, but it is marketed without FDA approval, so the FDA has not confirmed that the combination is safe and effective for that use.
Estrogen is the main female sex hormone. Before menopause the ovaries make most of it; afterward levels fall, and that drop is what drives hot flashes, vaginal dryness and faster bone loss. Esterified estrogens supplies estrogen by mouth. The body converts estrone sulfate into active estrogens, which attach to estrogen receptors in tissues that respond to the hormone, partly restoring the signals the ovaries used to send. Estrogen also makes the lining of the uterus grow. Left unchecked, that growth can lead to endometrial cancer, which is why people with a uterus take a progestin, a progesterone-like hormone, alongside estrogen. In the combination product, methyltestosterone adds an androgen, a hormone in the testosterone family. Whether it adds real benefit for hot flashes has not been established through FDA review.
Esterified estrogens is a tablet taken by mouth. For menopause symptoms, the labels describe cyclic use, for example three weeks on and one week off, at the lowest dose that controls symptoms. The combination tablets come in a full-strength version and a half-strength (H.S.) version, and the prescriber chooses which one and how many. The much higher doses once used for cancer palliation are a separate, specialist-directed use. Anyone with a uterus who takes estrogen should also take a progestin exactly as prescribed, because it protects the lining of the uterus. People who have had a hysterectomy do not need one. Check that the product and strength the pharmacy dispenses match the prescription, since several similar-sounding combination tablets exist.
Common effects include breast tenderness or swelling, changes in vaginal bleeding such as spotting or breakthrough bleeding, nausea, bloating, headache and fluid retention. Many of these settle, but vaginal bleeding that continues or keeps coming back should be reported, because it needs checking to rule out changes in the uterine lining, including cancer. The methyltestosterone in the combination product adds its own effects: acne, unwanted facial or body hair, scalp hair thinning and, in some people, a deeper voice or clitoral enlargement. Tell the prescriber about these early, because stopping at the first signs helps prevent changes that can become permanent. Methyltestosterone can also inflame the liver, so yellowing of the skin or eyes calls for prompt contact with the prescriber. Estrogen raises the risk of blood clots, stroke and heart attack. Sudden painful swelling in one leg, chest pain, shortness of breath, coughing up blood, face drooping, trouble speaking, sudden weakness or sudden loss of vision needs emergency care right away.
Estrogen therapy carries a boxed warning, the FDA's most prominent caution. In the Women's Health Initiative, a large trial in women aged 50 to 79 taking a related estrogen (conjugated estrogens) with a progestin, rates of heart attack, stroke, blood clots in the legs and lungs, and invasive breast cancer were higher than with placebo, and women 65 and older had a higher risk of probable dementia. The labels say to assume similar risks for other estrogens, not to use estrogen to prevent heart disease, and to use the lowest effective dose for the shortest time that meets treatment goals. Estrogen taken without a progestin raises the risk of endometrial cancer in people with a uterus, and estrogen also raises the risk of gallbladder disease. It is generally not used by people with unexplained vaginal bleeding, current or past breast cancer or another estrogen-sensitive cancer (except when treating advanced cancer), a current or past blood clot in the legs or lungs, a stroke or heart attack within about the past year, liver disease, or pregnancy. The methyltestosterone combination is also avoided while breastfeeding. St. John's wort and medicines that speed up estrogen breakdown, such as rifampin (an antibiotic) and the seizure medicines carbamazepine and phenobarbital, can make estrogen less effective. Ketoconazole and itraconazole (antifungals), clarithromycin (an antibiotic), ritonavir (an HIV medicine) and grapefruit juice can raise estrogen levels and side effects. Methyltestosterone can strengthen the effect of warfarin, a blood thinner, so clotting tests need closer checks when it is started or stopped. People taking thyroid hormone may need a dose review, because estrogen changes how thyroid hormone is carried in the blood. Before planned surgery or a long period of immobility, ask whether to pause estrogen; the labels suggest stopping 4 to 6 weeks ahead when feasible to lower clot risk.
Menopausal hormone therapy is the most effective treatment available for hot flashes and night sweats, and it also helps prevent bone loss. The North American Menopause Society's 2022 position statement finds the balance of benefit and risk most favorable for people without contraindications who start before age 60 or within 10 years of menopause, and less favorable for those who start later, because the absolute risks of heart disease, stroke, blood clots and dementia are higher then. That evidence comes from hormone therapy in general, not from studies of esterified estrogens specifically. Expect regular reviews, for example every 3 to 6 months as the labels suggest, to decide whether treatment is still needed and whether the dose can be lowered or tapered. Breast exams and mammograms continue on the schedule recommended for age and risk, and unexpected bleeding is investigated rather than ignored. Because single-ingredient esterified estrogens is no longer sold in the US and the combination product lacks FDA approval, it is reasonable to ask whether an FDA-approved estrogen would meet the same goals.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Esterified Estrogens, what you've noticed, or ask the community a question.